Rapamycin
Sirolimus
The most-studied lifespan-extending compound in animals; human longevity data still emerging.
- Status
- Rx
- Typical cost
- $30–$150 / mo
The core database
Every compound people ask about — what it does, what the human evidence actually shows, and how people access it. Conservative by design.
12 of 12 entries · select up to 3 to compare
Sirolimus
The most-studied lifespan-extending compound in animals; human longevity data still emerging.
Decades-old diabetes drug studied for healthy aging; strong safety record, unproven for longevity in non-diabetics.
A carb-blocking diabetes drug that robustly extends lifespan in male mice.
Ozempic / Wegovy
GLP-1 agonist with hard-outcome RCT data: weight loss and reduced cardiovascular events.
Mounjaro / Zepbound
Dual GIP/GLP-1 agonist producing the largest average weight loss of any approved drug.
Empagliflozin (Jardiance)
Glucose-lowering drugs with strong heart and kidney outcome data, even outside diabetes.
Nicotinamide mononucleotide, NR
Precursors that reliably raise blood NAD+; meaningful human health benefits remain unproven.
LDN
Tiny doses of an addiction drug, studied for chronic pain and inflammation.
TRT
Effective for diagnosed hypogonadism; the TRAVERSE trial eased cardiovascular concerns.
D+Q
The first senolytic combination; striking in mice, very early in humans.
An amino acid that declines with age; extended lifespan in mice, human trials pending.
A dietary polyamine that induces autophagy; human evidence is observational.
Not medical advice — talk to a licensed clinician. Content is educational, reflects published literature, and is not a recommendation to start, stop or change any treatment.